TY - JOUR
T1 - Gene-Gene Interaction Between Factor-XI and ABO Genes in Cerebral Venous Thrombosis
T2 - The BEAST Study
AU - Ken-Dror, Gie
AU - Martinelli, Ida
AU - Grandone, Elvira
AU - Hiltunen, Sini
AU - Lindgren, Erik
AU - Margaglione, Maurizio
AU - Le Cam Duchez, Veronique
AU - Triquenot, Aude B.
AU - Zedde, Marialuisa
AU - Mancuso, Michelangelo
AU - Ruigrok, Ynte M.
AU - Worrall, Bradford B.
AU - Majersik, Jennifer J.
AU - Putaala, Jukka
AU - Haapaniemi, Elena
AU - Zuurbier, Susanna
AU - Brouwer, Matthijs C.
AU - Passamonti, Serena M.
AU - Abbattista, Maria
AU - Bucciarelli, Paolo
AU - Lemmens, Robin
AU - Pappalardo, Emanuela
AU - Costa, Paolo
AU - Colombi, Marina
AU - De Sousa, Diana Aguiar
AU - Rodrigues, Sofia G.
AU - Canhao, Patrícia
AU - Tkach, Aleksander
AU - Santacroce, Rosa
AU - Favuzzi, Giovanni
AU - Arauz, Antonio
AU - Colaizzo, Donatella
AU - Spengos, Konstantinos
AU - Hodge, Amanda
AU - Ditta, Reina
AU - Pezzini, Alessandro
AU - Coutinho, Jonathan M.
AU - Thijs, Vincent N.
AU - Jood, Katarina
AU - Pare, Guillaume
AU - Tatlisumak, Turgut
AU - Ferro, José M.
AU - Sharma, Pankaj
N1 - Publisher Copyright:
© 2024 American Academy of Neurology.
PY - 2024/6/11
Y1 - 2024/6/11
N2 - BACKGROUND AND OBJECTIVES: Gene-gene interactions likely contribute to the etiology of multifactorial diseases such as cerebral venous thrombosis (CVT) and could be one of the main sources of known missing heritability. We explored Factor XI (F11) and ABO gene interactions among patients with CVT. METHODS: Patients with CVT of European ancestry from the large Bio-Repository to Establish the Aetiology of Sinovenous Thrombosis (BEAST) international collaboration were recruited. Codominant modelling was used to determine interactions between genome-wide identified F11 and ABO genes with CVT status. RESULTS: We studied 882 patients with CVT and 1,205 ethnically matched control participants (age: 42 ± 15 vs 43 ± 12 years, p = 0.08: sex: 71% male vs 68% female, p = 0.09, respectively). Individuals heterozygous (AT) for the risk allele (T) at both loci (rs56810541/F11 and rs8176645/ABO) had a 3.9 (95% CI 2.74-5.71, p = 2.75e-13) increase in risk of CVT. Individuals homozygous (TT) for the risk allele at both loci had a 13.9 (95% CI 7.64-26.17, p = 2.0e-15) increase in risk of CVT. The presence of a non-O blood group (A, B, AB) combined with TT/rs56810541/F11 increased CVT risk by OR = 6.8 (95% CI 4.54-10.33, p = 2.00e15), compared with blood group-O combined with AA. DISCUSSION: Interactions between factor XI and ABO genes increase risk of CVT by 4- to 14-fold.
AB - BACKGROUND AND OBJECTIVES: Gene-gene interactions likely contribute to the etiology of multifactorial diseases such as cerebral venous thrombosis (CVT) and could be one of the main sources of known missing heritability. We explored Factor XI (F11) and ABO gene interactions among patients with CVT. METHODS: Patients with CVT of European ancestry from the large Bio-Repository to Establish the Aetiology of Sinovenous Thrombosis (BEAST) international collaboration were recruited. Codominant modelling was used to determine interactions between genome-wide identified F11 and ABO genes with CVT status. RESULTS: We studied 882 patients with CVT and 1,205 ethnically matched control participants (age: 42 ± 15 vs 43 ± 12 years, p = 0.08: sex: 71% male vs 68% female, p = 0.09, respectively). Individuals heterozygous (AT) for the risk allele (T) at both loci (rs56810541/F11 and rs8176645/ABO) had a 3.9 (95% CI 2.74-5.71, p = 2.75e-13) increase in risk of CVT. Individuals homozygous (TT) for the risk allele at both loci had a 13.9 (95% CI 7.64-26.17, p = 2.0e-15) increase in risk of CVT. The presence of a non-O blood group (A, B, AB) combined with TT/rs56810541/F11 increased CVT risk by OR = 6.8 (95% CI 4.54-10.33, p = 2.00e15), compared with blood group-O combined with AA. DISCUSSION: Interactions between factor XI and ABO genes increase risk of CVT by 4- to 14-fold.
UR - http://www.scopus.com/inward/record.url?scp=85193565038&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000209445
DO - 10.1212/WNL.0000000000209445
M3 - Article
C2 - 38759137
AN - SCOPUS:85193565038
SN - 0028-3878
VL - 102
JO - Neurology
JF - Neurology
IS - 11
M1 - e209445
ER -